Medicaid GLP-1 coverage in Iowa, 2026.

Iowa Medicaid does not cover Wegovy for weight loss.

Coming change. From October 1, 2026, Iowa Medicaid changes its prior authorization rules for GLP-1s prescribed for something other than diabetes. October 2026 Iowa Medicaid Pharmacy Program Changes, dated August 20, 2026

Iowa last reviewed its drug list between July and September 2025.

Coverage summary

IndicationCoverage
Wegovy (weight loss)No
Zepbound (weight loss)No
Ozempic or Mounjaro (type 2 diabetes)Yes

If Iowa Medicaid says no, two cash programs to check.

No insurance needed.

  1. Strut Health$149 a month, with auto-refillcompounded semaglutideCheck price →You pick Weight Loss, then a five-minute online visit
  2. Shed$199 a month30% off first month with code Shed10compounded semaglutideCheck price →A health form first, then you choose your plan

Cheapest GLP-1 without insurance compares the three cash routes, and cheapest GLP-1 in Iowa prices each drug that ships there.

A clinical trial costs nothing, and nobody checks your income.

Prior-authorization criteria

These rules come from the state preferred drug list (PDL), the list of drugs Iowa Medicaid has agreed to pay for. Prior authorization means your doctor asks the plan to approve the drug before the pharmacy fills it. Nearly every state covers the diabetes path that way.

CriterionValue
How hard the approval isMedium
BMI threshold (weight-loss path)Not applicable (weight-loss path not covered)
Last PDL update reviewedbetween July and September 2025

If the plan denies it, the appeal letter templates cover the reasons plans give and what to send back.

What Iowa Medicaid paid for GLP-1s

Iowa Medicaid reported 21,595 GLP-1 prescriptions to CMS in 2025's last quarter and paid pharmacies $21.6 million.

Counts Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Rybelsus, in fee-for-service and managed care, before rebates. CMS blanks its smallest rows, so the real figures are higher. Source: CMS State Drug Utilization Data.

What this means in practice

Iowa Health Link MCOs follow the state PDL exclusion of weight-loss GLP-1. Diabetes coverage with PA is standard.

Managed-care organizations in Iowa

Iowa Medicaid pays private health plans, called managed-care organizations or MCOs, to run its coverage. An MCO has to cover at least what the state list covers and can add rules of its own. Check your own plan's current rules before you send anything in.

  • Amerigroup Iowa (Anthem)
  • Iowa Total Care (Centene)
  • Molina Healthcare of Iowa

Cash-pay alternatives if Medicaid does not cover you

If you end up paying cash, the GLP-1 cost guide has what each cash route costs, from the compounded floor to the manufacturer-direct brand prices. Federal law bars manufacturer savings cards for anyone on Medicaid.

If a supply gap rather than cost is blocking your refill, the GLP-1 shortage tracker shows which formulations the FDA lists as in shortage now. And if you are 65 or older and also have Medicare, the senior GLP-1 hub lays out the Medicare coverage paths for dual-eligible patients.

For the full cash-pay picture specific to Iowa, see the cheapest GLP-1 in Iowa guide.

10 GLP-1 clinical trials are recruiting in Iowa, and a study supplies its own study medication. Every site is listed on GLP-1 clinical trials in Iowa.

Iowa Medicaid GLP-1 FAQ

Does Iowa Medicaid cover Wegovy for weight loss?
No. Iowa Medicaid does not cover Wegovy for the weight-loss indication as of the 2025-Q3 preferred drug list review. If you have type 2 diabetes, the diabetes-indicated GLP-1s (Ozempic, Mounjaro) may still be covered with prior authorization.
Does Iowa Medicaid cover Zepbound for weight loss?
No. Iowa Medicaid does not cover Zepbound for the weight-loss indication as of the 2025-Q3 preferred drug list review. If you have type 2 diabetes, Mounjaro (tirzepatide, the same molecule as Zepbound) may be covered with prior authorization under the diabetes pathway.
Does Iowa Medicaid cover Ozempic or Mounjaro for diabetes?
Yes. Iowa Medicaid covers Ozempic and Mounjaro for type 2 diabetes with prior authorization, usually after a trial of metformin. The diabetes pathway does not carry the BMI threshold that applies to the weight-loss pathway.
What if Iowa Medicaid does not cover my GLP-1?
If your GLP-1 is not covered, the routes left do not run through Medicaid. A clinical trial costs nothing and many pay you for your time. Nobody checks your income. Manufacturer savings cards are not a route here, because federal law bars them for anyone on Medicaid. The cheapest route left is cash-pay compounded semaglutide, a pharmacy-made version that is not FDA-approved and is not Wegovy or Ozempic. The prices checked October 12, 2026 are on the chart. If you were denied, the appeal letter library has denial-specific templates.

Other state Medicaid pages

See the full 51-state coverage table for the side-by-side view across every US state.

How we built this page

Compiled from each state Medicaid's published preferred drug list, PA criteria and PDL committee minutes. State Medicaid programs are not federally required to cover obesity drugs; the diabetes indication is covered nearly everywhere with PA. State-level data is point-in-time and shifts each PDL cycle. Always verify with your state Medicaid plan before relying on this page.

Checked August 24, 2026. We check each state Medicaid PDL and PA criteria quarterly. If you have recently had a different experience with Iowa Medicaid, email hello@glpchart.com with the details and we will check it.

Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.